MDSpire - Summary
Feature

Dynamic, Accessible Risk Stratification Tool Created for Smoldering Multiple Myeloma

Researchers have developed a dynamic risk stratification tool for patients with smoldering multiple myeloma to predict their chance of progression to active multiple myeloma. The tool, called Precurso...

Share

Researchers have developed a dynamic risk stratification tool for patients with smoldering multiple myeloma called PANGEA-SMM, which effectively predicts progression to active disease. This online tool integrates evolving biomarker data and outperforms existing models like 20/2/20 and IMWG in accuracy. The cohort study included 2,344 patients across international centers. By monitoring changes in specific biomarkers, the tool helps identify high-risk patients who may require early intervention, enhancing patient management strategies.

Original Source(s)

Dynamic, Accessible Risk Stratification Tool Created for Smoldering Multiple Myeloma

  • by The ASCO Post Staff

  • March 27, 2026

Related Content

ASH 2025: Myelofibrosis Roundup

For myelofibrosis, the treatment landscape is poised for change as new targets have emerged, and treatments are evolving beyond the standard Janus kinase (JAK) inhibitors. Novel therapies are being pa...

POEMS Syndrome: Diagnostic Clues From Neuropathy to Bone Marrow Findings

POEMS syndrome is a poorly understood and complex paraneoplastic plasma cell disorder characterized by peripheral neuropathy and multisystem involvement, including organomegaly, endocrinopathy, monocl...

ASH 2025: Myelofibrosis Roundup

For myelofibrosis, the treatment landscape is poised for change as new targets have emerged, and treatments are evolving beyond the standard Janus kinase (JAK) inhibitors. Novel therapies are being pa...